ClinicalTrials.Veeva

Menu

Risk Factors of Porphyria Cutanea Tarda (PCT)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Porphyria Cutanea Tarda

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT.

Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Porphyria cutanea tarda /HCV negative Porphyria cutanea tarda/ HCV positive HCV positive HCV negative controls

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems